On January 11, 2023, the US International Trade Commission (ITC) has issued a ruling that Apple Inc. goes against Section 337 of the Tariff Act of 1930 as amended, 19 U.S.C. § 1337, by importing and selling certain Apple Watches with light-based pulse oximetry functionality and components which infringe upon claims 24 and 30 of Masimo’s U.S. Patent No. 10,945,648. The ITC is now considering whether to implement an import ban on these Apple Watches.
In Dec. 2022, the ITC issued a ruling that select Apple Watches with ECG functions infringed upon AliveCor’s patents.
In the above ruling, the ITC held that the Apple products did not violate the statute with respect to the asserted claims of Masimo’s U.S. Patent No. 10,912,501 (“the ‘501 patent”), U.S. Patent No. 10,912,502 (“the ‘502 patent”), U.S. Patent No. 10,687,745 (“the ‘745 patent”), or U.S. Patent No. 7,761,127 (“the ‘127 patent”). Although Apple’s Products were found to infringe claim 12 of the ‘501 patent, claims 22 and 28 of the ‘502 patent, and claims 12, 24, and 30 of the ‘648 patent, Claim 12 of the ‘501 patent, claim 28 of the ‘502 patent, and claim 12 of the ‘648 patent were ruled invalid.
Similarly in the ITC’s Order dated Dec. 22, 2022, it determined that Apple violated section 337 by reason of importation and sale of articles that infringe AliveCor’s asserted claims 12, 13, and 19-23 of U.S. Patent No. 10,638,941; and claims 1, 3, 5, 8-10, 12, 15, and 16 of U.S. Patent No. 10,595,731. However, the enforcement of these orders, including the bond provision, is suspended pending final resolution of the PTAB’s Final Written Decisions finding the asserted patent claims unpatentable; Apple, Inc. v. AliveCor, Inc., IPR2021-00971, Patent 10,595,731, Final Written Decision Determining All Challenged Claims Unpatentable (Dec. 6, ‘22); Apple, Inc. v. AliveCor, Inc., IPR2021-00972, Patent 10,638,941, Final Written Decision Determining All Challenged Claims Unpatentable (Dec. 6, 2022).
It will be interesting to see how these recent litigations pan out, given that both parties in each suit hold multiple patents. Then again, these lawsuits regarding new technology are old hat for Apple. It seems to have established a pattern of collaborating with new technology companies, vigorously pursuing internal R&D on this technology, bolstering its rights through filing a slew of patents for the results of its R&D inventions, and then striking it out on its own, at which point it is hit by these lawsuits from these other companies. This practice of the ‘development of new inhouse technology based on outside licensed technology’ has made it a party in more than 30 patent infringement suits in the past decade. The outcome in the currently pending lawsuits should act to effectively extinguish Apple’s predatory practices towards IP holders and bolster consistency in the IP licensing model for the industry.
Written by Lakshmidevi Somanath, currently law firm Partner, Surana & Surana International Attorneys, formerly Judge, IPAB, Government of India.